Evidence map›Paper›PMID 35152540›Full record

ArticleJournal of cosmetic dermatology2022

Newly-developed vitiligo following COVID-19 mRNA vaccine.

Ece Uğurer, Onur Sivaz, İlknur Kıvanç Altunay

Abstract readLetter
In one paragraph

Article in Journal of cosmetic dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Vogt-Koyanagi-Harada Disease and COVID.Journal of clinical medicine · 2023
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Newly-developed vitiligo following COVID-19 mRNA vaccine.Journal of cosmetic dermatology · 2022
    Article
  8. Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature.Clinical, cosmetic and investigational dermatology · 2022
    Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ece UğurerDepartment of Dermatology, Lüleburgaz State Hospital, Kırklareli, Turkey.
Onur SivazDepartment of Dermatology, Health Sciences University, Şişli Hamidiye Etfal Research and Training Hospital, Istanbul, Turkey.
İlknur Kıvanç AltunayDepartment of Dermatology, Health Sciences University, Şişli Hamidiye Etfal Research and Training Hospital, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19HypopigmentationVitiligoCOVID-19 VaccinesHumansmRNA VaccinesVaccines, SyntheticCOVID-19 VaccinesmRNA VaccinesVaccines, Synthetic

Identifiers

PMID35152540
PMCPMC9115282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.